Using light to support the tissue environment.
Photobiomodulation, often referred to as red or near-infrared light therapy, uses specific wavelengths of non-ionising light to influence biological activity within cells and tissues.
Unlike thermal treatments designed primarily to heat tissue, photobiomodulation is generally understood to act through light-sensitive cellular processes. Research has investigated its effects on mitochondrial activity, cellular signalling, inflammatory pathways, microcirculation, tissue repair and pain across a range of clinical applications.
There is also growing interest in the relationship between photobiomodulation and lymphatic function. Research in lymphoedema and other conditions involving tissue injury or inflammation has explored its potential role in supporting lymphatic and tissue responses.
However, evidence from these areas should not be interpreted as proof that photobiomodulation treats Lipoedema itself.
Within McLeod Method™, red and near-infrared light are used during the preparatory phase of the treatment sequence.
The rationale is to begin with a gentle, non-invasive intervention before progressing to more direct tissue-based modalities.
Its inclusion reflects the broader McLeod Method™ principle that tissue preparation should precede more intensive intervention.
Treatment parameters, device characteristics, individual tolerance and contraindications remain important considerations whenever photobiomodulation is used.
As research continues to develop, its role within the framework will continue to be evaluated against the available evidence.
Prepare first. Intervene second. Support throughout.
